![](/img/cover-not-exists.png)
Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial
Jones, Alexis, Muller, Patrick, Dore, Caroline J, Ikeji, Felicia, Caverly, Emilia, Chowdhury, Kashfia, Isenberg, David A, Gordon, Caroline, Ehrenstein, Michael RVolume:
9
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2019-032569
Date:
December, 2019
File:
PDF, 430 KB
2019